CIVICS PROGRAM - SARS-CoV-2 STUDIES

该合同支持创新候选疫苗和交付平台的设计和评估，旨在实现持久、强大和广泛的保护性免疫。活动可包括免疫学分析，为疫苗设计提供信息，并确定保护的替代物/相关物；体外、体内免疫原性及功效试验；试验和试剂开发；还有临床研究和试验。正在进行更多的研究，以评估对SARS-CoV-2感染的免疫反应。

This contract supports the design and evaluation of innovative vaccine candidates and delivery platforms that aim to achieve durable, robust and broadly protective immunity. Activities may include immunologic analyses to inform vaccine design and identify surrogates/correlates of protection; in vitro and in vivo immunogenicity and efficacy testing; assay and reagent development; and clinical studies and trials. Additional studies are being conducted to evaluate the immune response to SARS-CoV-2 infection.